{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T01:06:47Z","timestamp":1794272807187,"version":"4.9.0"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"44","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1097\/md.0000000000005307","type":"journal-article","created":{"date-parts":[[2016,11,3]],"date-time":"2016-11-03T10:58:36Z","timestamp":1478170716000},"page":"e5307","source":"Crossref","is-referenced-by-count":12,"title":["Predictive value of neutrophil-to-lymphocyte ratio in diagnosis of prostate cancer among men who underwent template-guided prostate biopsy"],"prefix":"10.1097","volume":"95","author":[{"given":"Tian-bao","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-yu","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-ming","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-jie","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Luan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang-chen","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-fei","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-73-20210309","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21332","article-title":"Cancer statistics, 2016","volume":"66","author":"Siegel","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"R2-73-20210309","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3322\/caac.21338","article-title":"Cancer statistics in China, 2015","volume":"66","author":"Chen","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"R3-73-20210309","doi-asserted-by":"crossref","first-page":"2054270415611332","DOI":"10.1177\/2054270415611332","article-title":"Neutrophil-lymphocyte ratio is prognostic but not predictive of response to Abiraterone in metastatic castration-resistant prostate cancer.","volume":"6","author":"Sundar","year":"2015","journal-title":"JRSM Open"},{"key":"R4-73-20210309","doi-asserted-by":"crossref","first-page":"e2544","DOI":"10.1097\/MD.0000000000002544","article-title":"Prognostic role of neutrophil-to-lymphocyte ratio in prostate cancer: a systematic review and meta-analysis","volume":"95","author":"Yin","year":"2016","journal-title":"Medicine (Baltimore"},{"key":"R5-73-20210309","doi-asserted-by":"crossref","first-page":"22089","DOI":"10.1038\/srep22089","article-title":"Prognostic significance of neutrophil-to-lymphocyte ratio in prostate cancer: evidence from 16,266 patients","volume":"6","author":"Gu","year":"2016","journal-title":"Sci Rep"},{"key":"R6-73-20210309","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12885-016-2134-3","article-title":"Pretreatment neutrophil-to-lymphocyte ratio predicts the prognosis in patients with metastatic prostate cancer","volume":"16","author":"Kawahara","year":"2016","journal-title":"BMC Cancer"},{"key":"R7-73-20210309","doi-asserted-by":"crossref","first-page":"e1473","DOI":"10.1097\/MD.0000000000001473","article-title":"Pretreatment neutrophil-to-lymphocyte ratio: a predictor of advanced prostate cancer and biochemical recurrence in patients receiving radical prostatectomy","volume":"94","author":"Zhang","year":"2015","journal-title":"Medicine (Baltimore"},{"key":"R8-73-20210309","doi-asserted-by":"crossref","first-page":"6407","DOI":"10.7314\/APJCP.2015.16.15.6407","article-title":"Predictive value of the platelet-to-lymphocyte ratio in diagnosis of prostate cancer","volume":"16","author":"Yuksel","year":"2015","journal-title":"Asian Pac J Cancer Prev"},{"key":"R9-73-20210309","first-page":"1","article-title":"Association of the neutrophil-to-lymphocyte ratio and prostate cancer detection rates in patients via contemporary multi-core prostate biopsy","volume":"17","author":"Oh","year":"2015","journal-title":"Asian J Androl"},{"key":"R10-73-20210309","doi-asserted-by":"crossref","first-page":"32169","DOI":"10.18632\/oncotarget.5081","article-title":"Neutrophil-to-lymphocyte ratio predicts prostatic carcinoma in men undergoing needle biopsy","volume":"6","author":"Kawahara","year":"2015","journal-title":"Oncotarget"},{"key":"R11-73-20210309","doi-asserted-by":"crossref","first-page":"E761","DOI":"10.5489\/cuaj.3091","article-title":"Evaluation of neutrophil-to-lymphocyte ratio prior to prostate biopsy to predict biopsy histology: results of 1836 patients","volume":"9","author":"Gokce","year":"2015","journal-title":"Can Urol Assoc J"},{"key":"R12-73-20210309","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3233\/CBM-150458","article-title":"Benign prostatic hyperplasia and prostate cancer differentiation via platelet to lymphocyte ratio","volume":"15","author":"Kaynar","year":"2015","journal-title":"Cancer Biomark"},{"key":"R13-73-20210309","doi-asserted-by":"crossref","first-page":"e4184","DOI":"10.1097\/MD.0000000000004184","article-title":"Effect of prostate volume on the peripheral nerve block anesthesia in the prostate biopsy: a strobe-compliant study","volume":"95","author":"Luan","year":"2016","journal-title":"Medicine (Baltimore"},{"key":"R14-73-20210309","doi-asserted-by":"crossref","first-page":"dju124","DOI":"10.1093\/jnci\/dju124","article-title":"Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis","volume":"106","author":"Templeton","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"R15-73-20210309","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1001\/archinte.167.17.1837","article-title":"Prospective study of leukocyte count as a predictor of incident breast, colorectal, endometrial, and lung cancer and mortality in postmenopausal women","volume":"167","author":"Margolis","year":"2007","journal-title":"Arch Intern Med"},{"key":"R16-73-20210309","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/aje\/kwr345","article-title":"White blood cell count and risk of gastric cancer incidence in a general Japanese population: the Hisayama study","volume":"175","author":"Iida","year":"2012","journal-title":"Am J Epidemiol"},{"key":"R17-73-20210309","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.critrevonc.2013.03.010","article-title":"The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer","volume":"88","author":"Guthrie","year":"2013","journal-title":"Crit Rev Oncol Hematol"},{"key":"R18-73-20210309","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1136\/jech.2006.051292","article-title":"A systematic review of the association between circulating concentrations of C reactive protein and cancer","volume":"61","author":"Heikkila","year":"2007","journal-title":"J Epidemiol Community Health"},{"key":"R19-73-20210309","first-page":"225","article-title":"Evaluation of increased preoperative serum high sensitive C-reactive protein and procalcitonin levels on grade and stage of clear cell renal cell carcinoma","volume":"83","author":"Hamidi","year":"2015","journal-title":"Clin Nephrol"},{"key":"R20-73-20210309","doi-asserted-by":"crossref","first-page":"e1861","DOI":"10.1097\/MD.0000000000001861","article-title":"Modified glasgow prognostic score is associated with risk of recurrence in bladder cancer patients after radical cystectomy: a multicenter experience","volume":"94","author":"Ferro","year":"2015","journal-title":"Medicine (Baltimore"},{"key":"R21-73-20210309","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.trsl.2014.06.006","article-title":"Prostate health index vs percent free prostate-specific antigen for prostate cancer detection in men with \u201cgray\u201d prostate-specific antigen levels at first biopsy: systematic review and meta-analysis","volume":"164","author":"Bruzzese","year":"2014","journal-title":"Transl Res"},{"key":"R22-73-20210309","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1002\/cncr.23461","article-title":"C-reactive protein as a prognostic marker for men with androgen-independent prostate cancer: results from the ASCENT trial","volume":"112","author":"Beer","year":"2008","journal-title":"Cancer"},{"key":"R23-73-20210309","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1002\/ijc.28313","article-title":"Prediagnostic circulating markers of inflammation and risk of prostate cancer","volume":"133","author":"Toriola","year":"2013","journal-title":"Int J Cancer"},{"key":"R24-73-20210309","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/pcan.2012.27","article-title":"Low serum neutrophil count predicts a positive prostate biopsy","volume":"15","author":"Fujita","year":"2012","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"R25-73-20210309","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0140-6736(00)04046-0","article-title":"Inflammation and cancer: back to Virchow?","volume":"357","author":"Balkwill","year":"2001","journal-title":"Lancet"},{"key":"R26-73-20210309","first-page":"184","article-title":"Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism","volume":"60","author":"Jaiswal","year":"2000","journal-title":"Cancer Res"},{"key":"R27-73-20210309","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0959-8049(99)00241-5","article-title":"The relationship between angiogenesis and the immune response in carcinogenesis and the progression of malignant disease","volume":"36","author":"O\u2019Byrne","year":"2000","journal-title":"Eur J Cancer"},{"key":"R28-73-20210309","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/sj.bjc.6690158","article-title":"Necrosis correlates with high vascular density and focal macrophage infiltration in invasive carcinoma of the breast","volume":"79","author":"Leek","year":"1999","journal-title":"Br J Cancer"},{"key":"R29-73-20210309","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"key":"R30-73-20210309","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer","volume":"420","author":"Coussens","year":"2002","journal-title":"Nature"},{"key":"R31-73-20210309","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.urolonc.2006.09.014","article-title":"Inflammation in the etiology of prostate cancer: an epidemiologic perspective","volume":"25","author":"Sutcliffe","year":"2007","journal-title":"Urol Oncol"},{"key":"R32-73-20210309","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jsbmb.2007.09.013","article-title":"Prostate growth and inflammation","volume":"108","author":"Sciarra","year":"2008","journal-title":"J Steroid Biochem Mol Biol"},{"key":"R33-73-20210309","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1442-2042.2012.03101.x","article-title":"Inflammation and prostate carcinogenesis","volume":"20","author":"Nakai","year":"2013","journal-title":"Int J Urol"},{"key":"R34-73-20210309","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1365-2559.2011.04033.x","article-title":"Prostate cancer and inflammation: the evidence","volume":"60","author":"Sfanos","year":"2012","journal-title":"Histopathology"},{"key":"R35-73-20210309","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00011-015-0812-2","article-title":"Inflammation and prostate cancer: friends or foe?","volume":"64","author":"Taverna","year":"2015","journal-title":"Inflamm Res"},{"key":"R36-73-20210309","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/ijc.30061","article-title":"Risk of prostate cancer in low-dose aspirin users: a retrospective cohort study","volume":"139","author":"Lapi","year":"2016","journal-title":"Int J Cancer"},{"key":"R37-73-20210309","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1002\/pros.23020","article-title":"Use of non-steroidal anti-inflammatory drugs and prostate cancer survival in the Finnish prostate cancer screening trial","volume":"75","author":"Veitonmaki","year":"2015","journal-title":"Prostate"},{"key":"R38-73-20210309","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1200\/JCO.2013.54.8875","article-title":"Daily aspirin use and prostate cancer-specific mortality in a large cohort of men with nonmetastatic prostate cancer","volume":"32","author":"Jacobs","year":"2014","journal-title":"J Clin Oncol"},{"key":"R39-73-20210309","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1007\/s11255-014-0703-4","article-title":"Aspirin use and the risk of prostate cancer: a meta-analysis of 24 epidemiologic studies","volume":"46","author":"Huang","year":"2014","journal-title":"Int Urol Nephrol"},{"key":"R40-73-20210309","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/(SICI)1097-0045(20000101)42:1<73::AID-PROS9>3.0.CO;2-G","article-title":"Over-expression of cyclooxygenase-2 in human prostate adenocarcinoma","volume":"42","author":"Gupta","year":"2000","journal-title":"Prostate"},{"key":"R41-73-20210309","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0090-4295(00)00674-9","article-title":"Expression of cyclooxygenase-1 and cyclooxygenase-2 in the human prostate","volume":"56","author":"Kirschenbaum","year":"2000","journal-title":"Urology"},{"key":"R42-73-20210309","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1023\/A:1020915914376","article-title":"Requirement of cyclooxygenase-2 expression and prostaglandins for human prostate cancer cell invasion","volume":"19","author":"Nithipatikom","year":"2002","journal-title":"Clin Exp Metastasis"},{"key":"R43-73-20210309","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(09)60243-9","article-title":"Aspirin, salicylates, and cancer","volume":"373","author":"Elwood","year":"2009","journal-title":"Lancet"},{"key":"R44-73-20210309","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2004.06.014","article-title":"Cyclooxygenases in cancer: progress and perspective","volume":"215","author":"Zha","year":"2004","journal-title":"Cancer Lett"},{"key":"R45-73-20210309","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1056\/NEJM199902113400607","article-title":"Acute-phase proteins and other systemic responses to inflammation","volume":"340","author":"Gabay","year":"1999","journal-title":"N Engl J Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000005307","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T10:00:15Z","timestamp":1718877615000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201611010-00073"}},"subtitle":["A STROBE-compliant study"],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":45,"journal-issue":{"issue":"44","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000005307","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]}}}